What are your top takeaways in Radiation Oncology from SABCS 2025?

Several significant studies were presented at San Antonio this year. I will focus on the three most important abstracts reporting new data from studies of local-regional therapy. (The 10-year update of the BIG 3-07-TROG 07.01 trial comparing hypofractionated and conventional fractionation and the use of a boost or not in patients with "high risk" DCIS was also presented; Chua BH, Abstract GS2-12. The results again showed that giving a boost reduced the recurrence rate but worsened cosmetic resul...